科研之友
微信
新浪微博
Facebook
分享链接
摘要
Introduction: With the AnaConDa (TM) system, inhalational sedation in the intensive care unit has become popular. The device can be used with common intensive care unit ventilators and is inserted between the Y-piece and the patient. Liquid isoflurane or sevoflurane are delivered by a syringe pump. 90 % of anesthetic exhaled by the patient is absorbed by a reflector and resupplied during the next inspiration. The new Mirus (TM) system also uses a reflector. Its control unit identifies end-tidal concentrations from the flow, injects anesthetics during early inspiration, controls anesthetic concentrations automatically, and can also apply desflurane. The AnaConDa (TM) and Mirus (TM) system are certified 'conformite etabli', however, little is known about the Mirus (TM) and case reports are still lacking. Case description: We used the Mirus (TM) with desflurane for 24 h in a patient suffering from acute respiratory distress syndrome. The patient was treated with kinetic lateral rotational therapy. While deeply sedated, our patient breathed 9.0-12.0 broken vertical bar min(-1) spontaneously. Thereafter, awakening and wash-out were considerably shorter than after isoflurane in the same patient with AnaConDa (TM). There were no major problems during the sedation. However, consumption of desflurane was high. Conclusion: Desflurane sedation with the Mirus (TM) seems promising, but the reflector should be improved to absorb and resupply more of the anesthetic agent.
- 出版日期2016-4-6
